What volume of diluent should be used to reconstitute a 1‑gram cefepime vial?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 25, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Reconstitution of 1 Gram Cefepime Vial

For a 1-gram cefepime vial intended for intravenous administration, the FDA-approved premixed formulation uses 50 mL of diluent, though this represents the final ready-to-use solution rather than initial powder reconstitution instructions. 1

Standard Reconstitution Volume

The available evidence does not provide explicit powder-to-diluent reconstitution volumes for the 1-gram vial in the FDA labeling reviewed. However, based on related cephalosporin reconstitution practices from guideline evidence:

  • For cefazolin or ceftazidime 1-gram vials (similar cephalosporins), 9.2 mL of diluent is added to achieve approximately 10 mL final volume 2
  • This creates an initial concentration of approximately 100 mg/mL after reconstitution

Clinical Context

The FDA-approved premixed cefepime formulation contains 1 gram in 50 mL (20 mg/mL concentration) for direct intravenous infusion 1

Key Reconstitution Principles:

  • Use sterile water for injection, 0.9% sodium chloride, or 5% dextrose as diluent 1
  • Reconstituted solutions should be used promptly due to time-dependent instability beyond 24 hours 3
  • The solution will range from colorless to amber after reconstitution 1

Important Caveats

Cefepime demonstrates physical incompatibility with certain intravenous fluids beyond 1 hour at concentrations of 10-40 mg/mL, particularly with 0.45% sodium chloride, Ringer's lactate, and Plasma-Lyte A 4. This emphasizes the importance of:

  • Using appropriate diluents (normal saline or D5W preferred)
  • Administering reconstituted solutions promptly
  • Avoiding prolonged storage of diluted solutions

For powder vial reconstitution, consult the specific manufacturer's package insert accompanying your vial, as reconstitution volumes may vary by manufacturer and are not fully detailed in the premixed formulation labeling reviewed.

References

Research

Compatibility of cefepime and vancomycin during simulated Y-site administration of prolonged infusion.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2015

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.